Bodycote (LON:BOY)‘s stock had its “outperform” rating reiterated by equities research analysts at Credit Suisse in a research note issued to investors on Thursday, Analyst Ratings Net reports. They currently have a GBX 760 ($12.43) price objective on the stock. Credit Suisse’s target price would suggest a potential upside of 23.38% from the stock’s previous close.
Bodycote (LON:BOY) opened at 606.50 on Thursday. Bodycote has a 52 week low of GBX 426.30 and a 52 week high of GBX 691.00. The stock’s 50-day moving average is GBX 637.1 and its 200-day moving average is GBX 612.3. The company’s market cap is £1.148 billion.
A number of other firms have also recently commented on BOY. Analysts at JPMorgan Chase & Co. reiterated an “underweight” rating on shares of Bodycote in a research note to investors on Friday, November 22nd. They now have a GBX 540 ($8.83) price target on the stock. Separately, analysts at Jefferies Group raised their price target on shares of Bodycote from GBX 605 ($9.89) to GBX 710 ($11.61) in a research note to investors on Wednesday, November 20th. They now have a “buy” rating on the stock. Finally, analysts at N+1 Singer reiterated a “buy” rating on shares of Bodycote in a research note to investors on Tuesday, November 19th. They now have a GBX 700 ($11.45) price target on the stock. Three investment analysts have rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of GBX 644.98 ($10.55).
Bodycote plc (LON:BOY) is a specialized plasma spray, high velocity oxy fuel (HVOF) and thermally formed ceramic treatments.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.